Article
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
12 Feb 2021
Abstract excerpt
Glioblastoma multiforme (GBM) is amongst the deadliest of human cancers, with a median survival rate of just over one year following diagnosis. Characterized by rapid proliferation and diffuse infiltration into the brain, GBM is notoriously difficult to treat, with tumor cells showing limited response to existing therapies and eventually developing resistance to these interventions. As such, there is intense...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
